Physician

Amy M Evangelisto, MD

According to 2025 Medicare claims, Amy Evangelisto, MD (NPI: 1023119195) practices rheumatology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is TRABECULAR MEDICAL GROUP, LLC (NPI: 1427622661; TIN: 851604336) and primary practice location at 08043-1559. Evangelisto is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Evangelisto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 713 traditional Medicare patients, billed 94,002 HCPCS/CPT codes, and received $1,125,441 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,888 prescription claims across 370 beneficiaries totaling $1,427,480 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 6 records totaling $161. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $652,432 to $1,125,441. Similarly, Part D prescription costs have moved sharply higher in recent years, from $227,525 to $1,427,480. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	654	27,483	$652,432
2016	655	31,122	$773,305
2017	739	36,704	$820,605
2018	951	43,817	$943,025
2019	766	56,211	$1,040,328
2020	750	85,521	$1,359,436
2021	684	100,960	$1,259,019
2022	660	92,432	$1,275,615
2023	720	95,879	$1,219,590
2024	713	94,002	$1,125,441

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	218	1,177	$227,525
2016	232	1,173	$254,238
2017	239	1,218	$423,758
2018	240	1,098	$408,230
2019	285	1,422	$877,099
2020	286	1,492	$823,680
2021	286	1,587	$852,144
2022	338	1,748	$1,250,545
2023	369	1,812	$1,453,725
2024	370	1,888	$1,427,480

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	134	204	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	380	614	$100
76882	Limited ultrasound scan of joint or other extremity structure except blood vessels	173	374	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	249	322	$14
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	173	1,716	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	32	1,064	$276,970
Humira(Cf) Pen	Adalimumab	30	840	$219,658
Cosentyx Sensoready Pen	Secukinumab	20	634	$181,295
Orencia Clickject	Abatacept	14	392	$77,820
Simponi	Golimumab	12	360	$68,933

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$161	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy M. Evangelisto, MD?

Tedicare shows public-source Medicare data for Amy M. Evangelisto, MD (NPI 1023119195), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy M. Evangelisto, MD have ACO affiliation data?

Amy M. Evangelisto, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Amy M. Evangelisto, MD?

Amy M. Evangelisto, MD is linked to TRABECULAR MEDICAL GROUP, LLC (billing NPI 1427622661) in the available physician profile data.

Does Amy M. Evangelisto, MD have Open Payments data?

Amy M. Evangelisto, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.